The kit is designed for purification of circulating cfNDA and uses silica coated paramagnetic particles to purify cfDNA from less than 1 mL to greater than 10 mL of serum or plasma.
Each of the new panels comes with ERASE-Seq, Fluxion's variant caller which uses statistical analysis to compare sequencing results across several molecular amplification pools.
Biocept's Target Selector test enables physicians to identify the potential presence of NTRK fusions used to inform on treatment options.
The new clinical report, Cardiac Care, features more than 110 genes from clinical databases spanning more than 30 different cardiovascular conditions, ranging from cardiomyopathies to rare forms of long QT syndromes.
NanoString Technologies has announced the launch of nCounter Human Organ Transplant, a gene expression panel for researchers to evaluate the human immune response following organ transplantation.
PerkinElmer has introduced the PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing for Aneuploidy (PGT-A) kit, that tests spent embryo culture media for chromosomal abnormalities during in vitro fertilization (IVF) treatment.
The new Streck ARM-D Kits detect the most clinically important current and emerging antimicrobial resistance threats.
Bio-Rad Laboratories launched the Reliance One-Step Multiplex Supermix, a ready-to-use, single-tube reagent mix optimized for sensitive amplification of up to five targets in a...
Oncology Analytics announced the release of Oncology Insights, a next-generation analytics software solution that delivers current, relevant, and structured oncology data, supported by expert...
Liquid biopsy test provider Biocept has announced Target Selector NGS Breast Panel, a multi-gene liquid biopsy panel specifically developed for breast cancer. The Target...